Cargando…
MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model
A dual microRNA-detargeted oncolytic Mengovirus, vMC(24)NC, proved highly effective against a murine plasmacytoma in an immunocompetent syngeneic mouse model; however, there remains the concern of escape mutant development and the potential for toxicity in severely immunocompromised cancer patients...
Autores principales: | Suryawanshi, Yogesh R., Nace, Rebecca A., Russell, Stephen J., Schulze, Autumn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455367/ https://www.ncbi.nlm.nih.gov/pubmed/34589580 http://dx.doi.org/10.1016/j.omto.2021.08.011 |
Ejemplares similares
-
MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy
por: Ruiz, Autumn J., et al.
Publicado: (2016) -
Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model
por: Penza, Velia, et al.
Publicado: (2022) -
Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021) -
Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5
por: Nguyen, Tien V., et al.
Publicado: (2017) -
Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA
por: Elsedawy, Noura B., et al.
Publicado: (2020)